3D hepatocyte monolayer on hybrid RGD/galactose substratum

被引:90
作者
Du, Yanan
Chia, Ser-mien
Han, Rongbin
Chang, Shi
Tang, Huihuan
Yu, Hanry
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore
[2] Natl Univ Singapore, Sch Integrat Sci & Engn, Grad Program Bioengn, Singapore 117597, Singapore
[3] Cent S Univ, Dept Gen Surg, Xiang Ya Hosp, Changsha 410008, Peoples R China
[4] Inst Bioengn & Nanotechnol, Singapore 138669, Singapore
基金
英国医学研究理事会;
关键词
surface modification; RGD peptide; galactosylation; hybrid biomaterial; hepatocyte; hepatotoxicity;
D O I
10.1016/j.biomaterials.2006.07.018
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Hepatocyte-based applications such as xenobiotics metabolism and toxicity studies usually require hepatocytes anchoring onto flat substrata that support their functional maintenance. Conventional cell culture plates coated with natural matrices or synthetic ligands allow hepatocytes to adhere tightly as two-dimensional (2D) monolayer but these tightly anchored hepatocytes rapidly lose their differentiated functions. On galactosylated substrata, hepatocytes adhere loosely; and readily form three-dimensional (3D) spheroids that can maintain high levels of cellular functions. These spheroids detach easily from the substrata and exhibit poor mass transport properties unsuitable for many applications. Here, we have developed a hybrid RGD/galactose substratum based on polyethylene terephthalate film conjugated with both RGD peptide and galactose ligand to enhance cell adhesion and functions synergistically. Primary hepatocytes adhere effectively onto the transparent hybrid substratum in 96-well plates as monolayer while exhibiting high levels of liver-specific functions, morphology and cell-cell interactions typically seen in the 3D hepatocyte spheroids. The hepatocytes cultured onto the hybrid substratum also exhibit high levels of sensitivity to a model drug acetaminophen similar to the 3D hepatocyte spheroids. The monolayer of hepatocytes exhibiting the 3D cell behaviors on this flat hybrid substratum can be useful for various applications requiring both effective mass transfer and cellular support. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5669 / 5680
页数:12
相关论文
共 52 条
[1]   Advances in bioartificial liver devices [J].
Allen, JW ;
Hassanein, T ;
Bhatia, SN .
HEPATOLOGY, 2001, 34 (03) :447-455
[2]   Engineering cellular microenvironments to cell-based drug testing improve [J].
Bhadriraju, K ;
Chen, CS .
DRUG DISCOVERY TODAY, 2002, 7 (11) :612-620
[3]   ACETAMINOPHEN HEPATOTOXICITY [J].
BLACK, M .
ANNUAL REVIEW OF MEDICINE, 1984, 35 :577-593
[4]   MEMBRANE TOPOLOGY OF THE MAMMALIAN P450-CYTOCHROMES [J].
BLACK, SD .
FASEB JOURNAL, 1992, 6 (02) :680-685
[5]   ASSAY FOR NANOGRAM QUANTITIES OF DNA IN CELLULAR HOMOGENATES [J].
BRUNK, CF ;
JONES, KC ;
JAMES, TW .
ANALYTICAL BIOCHEMISTRY, 1979, 92 (02) :497-500
[6]   Bioreactors for hybrid liver support: Historical aspects and novel designs [J].
Busse, B ;
Gerlach, JC .
BIOARTIFICIAL ORGANS II: TECHNOLOGY, MEDICINE, AND MATERIALS, 1999, 875 :326-339
[7]   Enhancing hepatocyte adhesion by pulsed plasma deposition and polyethylene glycol coupling [J].
Carlisle, ES ;
Mariappan, MR ;
Nelson, KD ;
Thomes, BE ;
Timmons, RB ;
Constantinescu, A ;
Eberhart, RC ;
Bankey, PE .
TISSUE ENGINEERING, 2000, 6 (01) :45-52
[8]   Hepatocyte encapsulation for enhanced cellular functions [J].
Chia, SM ;
Leong, KW ;
Li, J ;
Xu, X ;
Zeng, KY ;
Er, PN ;
Gao, SJ ;
Yu, H .
TISSUE ENGINEERING, 2000, 6 (05) :481-495
[9]   Galactose-carrying polymers as extracellular matrices for liver tissue engineering [J].
Cho, CS ;
Seo, SJ ;
Park, IK ;
Kim, SH ;
Kim, TH ;
Hoshiba, T ;
Harada, I ;
Akaike, T .
BIOMATERIALS, 2006, 27 (04) :576-585
[10]   The use of long-term hepatocyte cultures for detecting induction of drug metabolising enzymes: The current status - ECVAM hepatocytes and metabolically competent systems task force report 1 [J].
Coecke, S ;
Rogiers, V ;
Bayliss, M ;
Castell, J ;
Doehmer, J ;
Fabre, G ;
Fry, J ;
Kern, A ;
Westmoreland, C .
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 1999, 27 (04) :579-638